These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 191300)

  • 1. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
    Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH
    N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF; Laragh JH
    Urol Clin North Am; 1975 Jun; 2(2):237-57. PubMed ID: 1098253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II blockade and the functions of the renin-angiotensin system.
    Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM
    Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
    Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA; Mitchell HC
    Fed Proc; 1976 Nov; 35(13):2521-5. PubMed ID: 976494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polypeptides and antagonists].
    Regoli D
    Sem Hop; 1984 Mar; 60(14):987-1002. PubMed ID: 6202006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.